{"id":"NCT00085644","sponsor":"Abbott","briefTitle":"Human Anti-tumor Necrosis Factor (TNF) Monoclonal Antibody Adalimumab in Subjects With Active Ankylosing Spondylitis","officialTitle":"A Phase 3 Multicenter Study of the Safety and Efficacy of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Active Ankylosing Spondylitis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2004-01","primaryCompletion":"2004-12","completion":"2009-07","firstPosted":"2004-06-16","resultsPosted":"2010-03-11","lastUpdate":"2011-04-21"},"enrollment":315,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Ankylosing Spondylitis"],"interventions":[{"type":"BIOLOGICAL","name":"adalimumab (D2E7)","otherNames":["ABT-D2E7","adalimumab","Humira"]},{"type":"BIOLOGICAL","name":"placebo","otherNames":[]}],"arms":[{"label":"Adalimumab","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The objective of this study was to evaluate the safety and efficacy of adalimumab 40 mg given every other week (eow) in subjects with active ankylosing spondylitis (AS) who have had an inadequate response to, or who are intolerant to, treatment with at least 1 nonsteroidal anti-inflammatory drug (NSAID) and who may have also failed treatment with at least 1 disease-modifying antirheumatic drug (DMARD).","primaryOutcome":{"measure":"Number of Responders With a Reduction of Signs and Symptoms of Ankylosing Spondylitis (AS) as Measured With ASAS International Working Group Response Criteria (ASAS 20).","timeFrame":"Week 12","effectByArm":[{"arm":"Adalimumab","deltaMin":121,"sd":null},{"arm":"Placebo","deltaMin":22,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"< 0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":8},"locations":{"siteCount":22,"countries":["United States"]},"refs":{"pmids":["25541333","21813060","21600054","20100797","19703304","19686597","18701556","18383418","18056755"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":96,"n":311},"commonTop":["Nasopharyngitis","Upper respiratory tract infection","Ankylosing spondylitis","Headache","Arthralgia"]}}